CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-16 | Gergel Ivan P. SVP & Chief Medical Officer | Returned to the company | −5,022 | $44.23 | $222K | 56,553 |
| 2017-11-15 | Gergel Ivan P. SVP & Chief Medical Officer | Grant or award | +20,000 | 61,575 | ||
| 2017-11-15 | Gergel Ivan P. SVP & Chief Medical Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2017-10-02 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion | +56,704 | $11.04 | $626K | 98,279 |
| 2017-10-02 | Gergel Ivan P. SVP & Chief Medical Officer | Sale | −56,704 | $24.21 | $1.4M | 41,575 |
| 2017-10-02 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion · Stock Option | −56,704 | 313,752 | ||
| 2017-09-29 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion | +43,296 | $11.04 | $478K | 84,871 |
| 2017-09-29 | Gergel Ivan P. SVP & Chief Medical Officer | Sale | −43,296 | $24.04 | $1.0M | 41,575 |
| 2017-09-29 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion · Stock Option | −43,296 | 370,456 | ||
| 2017-08-16 | Gergel Ivan P. SVP & Chief Medical Officer | Sale | −1,997 | $19.32 | $39K | 41,575 |
| 2017-07-18 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion | +54,920 | $11.04 | $606K | 98,492 |
| 2017-07-18 | Gergel Ivan P. SVP & Chief Medical Officer | Sale | −54,920 | $21.10 | $1.2M | 43,572 |
| 2017-07-18 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion · Stock Option | −54,920 | 413,752 | ||
| 2017-07-12 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion | +36,691 | $11.04 | $405K | 80,263 |
| 2017-07-12 | Gergel Ivan P. SVP & Chief Medical Officer | Sale | −36,691 | $21.09 | $774K | 43,572 |
| 2017-07-12 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion · Stock Option | −36,691 | 468,672 | ||
| 2017-07-11 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion | +8,389 | $11.04 | $93K | 51,961 |
| 2017-07-11 | Gergel Ivan P. SVP & Chief Medical Officer | Sale | −8,389 | $21.04 | $177K | 43,572 |
| 2017-07-11 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion · Stock Option | −8,389 | 505,363 | ||
| 2017-05-16 | Gergel Ivan P. SVP & Chief Medical Officer | Sale | −1,450 | $19.55 | $28K | 43,572 |
Page 1 of 2 · 35 trades